Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.575 USD | +1.45% | -6.09% | -21.45% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-21.45% | 5.93M | |
+31.95% | 694B | |
+29.51% | 593B | |
-1.72% | 371B | |
+19.24% | 331B | |
+6.74% | 290B | |
+14.17% | 239B | |
-3.11% | 209B | |
+9.99% | 209B | |
+8.35% | 169B |
- Stock Market
- Equities
- TTNP Stock
- News Titan Pharmaceuticals, Inc.
- Transcript : Titan Pharmaceuticals, Inc., Q2 2017 Earnings Call, Aug 09, 2017